Abstract Significance: The antiulcer peptide, stable gastric pentadecapeptide BPC 157 (previously employed in ulcerative colitis and multiple sclerosis trials, no reported toxicity (LD1 not achieved)), is reviewed, focusing on the particular skin wound therapy, incisional/excisional wound, deep burns, diabetic ulcers, and alkali burns, which may be generalized to the other tissues healing
Repair & Glow is not prescribed to patients who are pregnant or breastfeeding, have active cancer or a recent cancer history (because BPC-157 and TB-500 promote angiogenesis, which could theoretically support tumor growth), or are under 18
Pale yellow urine usually indicates proper hydration
People with immune sensitivities or those in regulated sports (where BPC 157 use may be restricted) should be particularly careful
Dose volume: 250 mcg 5,000 mcg/mL = 0.05 mL
supplementation is a clinical necessity, not an optional measure